title: Evaluation of the role of timolol 0.1% gel in myopic regression after laser in situ keratomileusis.
abstract: OBJECTIVE
  To evaluate the efficacy of the concomitant administration of antiglaucoma medications namely timolol 0.1% gel in cases with myopic regression after myopic laser in situ keratomileusis (LASIK).
  
  
  METHODS
  Prospective observational clinical trial.
  
  
  METHODS
  Ninty five eyes of 75 patients were included in this study prospectively. The mean myopic regression was -1.29 ± 0.83 diopters (range -0.5 to -4.62) after myopic LASIK. The eyes were divided into two groups: 50 eyes administrated timolol 0.1% gel once daily for 12 months (treated group), and 45 eyes were age matched (control group). We assessed the amounts of myopic regression in terms of changes in the refraction (spherical equivalent and astigmatism), intraocular pressure (IOP), pachymetry and the refractive power of the cornea measurements for all participants.
  
  
  RESULTS
  The refractive error and visual acuity were similar between the two groups at baseline. The treated group had an improvement in spherical equivalent significantly from -1.29 ± 0.83 to -0.94 ± 1.07 diopters (P = 0.012). Astigmatism was changed from -0.94 ± 0.53 to -0.86 ± 0.60 diopters but this change was not statistically significant (P = 0.20). The IOP was decreased significantly from 12.6 ± 1.9 to 9.0 ± 1.1 mm Hg (P < 0.001). Central corneal thickness was changed from 425.6 ± 19.86 to 429 ± 18.1 μm but not statistically significant (P = 0.56). The central corneal power decreased significantly from 37.2 ± 1.8 to 36.4 ± 1.3 diopters (P < 0.05).
  
  
  CONCLUSIONS
  Timolol 0.1% gel was effective for reduction and improvement of myopic regression especially the spherical errors after myopic LASIK.
authors: Mansoura Ophthalmic Center, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
authors: Hatem E
authors: HE
authors: El-Awady
authors: Asaad A
authors: AA
authors: Ghanem
authors: Mohamed A
authors: MA
authors: Gad
keywords: Myopic LASIK; Myopic regression; Timolol 0.1% gel
references: J Cataract Refract Surg. 1999 May;25(5):712-5
references: 10330651
references: Semin Ophthalmol. 2003 Mar;18(1):17-22
references: 12759856
references: J Cataract Refract Surg. 2005 Aug;31(8):1652-5
references: 16129306
references: Ophthalmology. 2001 Feb;108(2):317-20
references: 11158806
references: J Cataract Refract Surg. 2005 Jan;31(1):202-4
references: 15721714
references: Arch Ophthalmol. 2002 Jul;120(7):896-900
references: 12096959
references: Semin Ophthalmol. 1998 Jun;13(2):79-82
references: 9758652
references: Ophthalmologica. 2004 Mar-Apr;218(2):96-101
references: 15004497
references: Ophthalmologica. 2002 Nov-Dec;216(6):449-54
references: 12566891
references: Ophthalmologica. 2006;220(4):272-6
references: 16785760
references: Ophthalmology. 2000 Jul;107(7):1235-45
references: 10889092
references: J Cataract Refract Surg. 2001 Jul;27(7):1007-12
references: 11489568